Erik Kinnman, a seasoned life science executive, has been appointed chief executive officer of Sweden-based NeuroVive Pharmaceutical AB. Most recently a consultant, Dr Kinnman has also held senior positions at AstraZeneca Plc and Swedish Orphan Biovitrum AB (Sobi). He is a medical doctor and certified to practice in neurology and pain management. He is also a graduate of the Stockholm School of Economics and the Karolinska Institutet. Dr Kinnman is expected to help NeuroVive refocus on research and development. The company is a pioneer in mitochondrial medicines.
The appointment will take effect on 14 March 2016.
Copyright 2016 Evernow Publishing Ltd